Gabriel Izbicki
Overview
Explore the profile of Gabriel Izbicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
711
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bohadana A, Wild P, Rokach A, Berg A, Izbicki G
Lung
. 2024 Nov;
203(1):3.
PMID: 39601892
Purpose: In aging populations, the Global Initiative for Obstructive Lung Disease (GOLD) spirometry threshold may misclassify normal spirometry as airflow limitation. The Global Lung Initiative (GLI) method provides age-adjusted criteria....
2.
Arish N, Izbicki G, Rokach A, Jarjoui A, Kalak G, Goldberg S
PLoS One
. 2023 Jul;
18(7):e0284063.
PMID: 37463178
Patients with coronavirus 2019 (COVID-19) and obstructive sleep apnoea (OSA) have a worse prognosis than COVID-19 patients without OSA. This study aimed to examine the relationship between OSA risk and...
3.
Bohadana A, Rokach A, Wild P, Kotek O, Shuali C, Azulai H, et al.
Chronic Obstr Pulm Dis
. 2023 May;
10(3):248-258.
PMID: 37200614
Background: Chronic obstructive pulmonary disease (COPD) case-finding aims to detect airflow obstruction in symptomatic smokers and ex-smokers. We used a clinical algorithm including smoking, symptoms, and spirometry to classify smokers...
4.
Kalak G, Jarjoui A, Bohadana A, Wild P, Rokach A, Amiad N, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36556030
COVID-19 is characterized by persistent symptoms beyond acute illness. In this prospective cohort study of patients with COVID-19, we sought to characterize the prevalence and persistence of symptoms up to...
5.
Bohadana A, Rokach A, Wild P, Peker B, Dror Y, Babai P, et al.
Chronic Obstr Pulm Dis
. 2022 Jul;
9(4):486-499.
PMID: 35877930
Background: Although smoking is the leading cause of chronic obstructive pulmonary disease (COPD), many patients with COPD smoke, highlighting the need for effective smoking cessation interventions in this population. This...
6.
Arish N, Rokach A, Jarjoui A, Bogot N, Halperen I, Md M, et al.
Isr Med Assoc J
. 2022 Jan;
24(1):61-63.
PMID: 35077049
No abstract available.
7.
Pertzov B, Soliman M, Shostak Y, Heching M, Rosengarten D, Izbicki G, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Oct;
16:2809-2815.
PMID: 34675505
Background: Lung volume reduction with endobronchial coils treatment (ECT), for patients with severe emphysema, has shown modest improvement in exercise capacity and lung functions in clinical trials, yet the benefit...
8.
Kurd R, Freed Y, Jarjoui A, Izbicki G, Levin P, Helvitz Y, et al.
Complement Med Res
. 2021 Sep;
29(1):83-88.
PMID: 34521083
Background: Severe acute respiratory syndrome due to coronavirus 2 (SARS CoV-2) is a novel infectious disease, which has quickly developed into a pandemic. The spectrum of COVID-19 symptoms is broad,...
9.
Jarjoui A, Bogot N, Kalak G, Chen-Shuali C, Rokach A, Izbicki G, et al.
Respirol Case Rep
. 2021 Sep;
9(10):e0839.
PMID: 34484796
Pulmonary calcifications are usually incidental asymptomatic findings discovered on x-rays or computed tomography scans that can be easily overlooked, and their significance undermined, especially in a seemingly asymptomatic person. Calcifications...
10.
Rokach A, Bohadana A, Kotek O, Shuali C, Azulai H, Babai P, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Jun;
16:1519-1527.
PMID: 34103909
Background: Different case finding approaches have been used to identify early COPD. The objective of this study was to assess the feasibility and the yield of opportunistic early COPD case...